Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure
Open accessAbstract
Objectives The purpose of this study was to investigate the influence of diabetes on long-term mortality in a large cohort of patients hospitalized with heart failure (HF).Background Diabetes is common in HF patients, but information on the prognostic effect of diabetes is sparse.Methods The study is an analysis of survival data comprising 5,491 patients consecutively hospitalized with new or worsening HF and screened for entry into the Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND). Screening, which included obtaining an echocardiogram in 95% of the patients, took place at Danish hospitals between 1993 and 1995. The follow-up time was five to eight years.Results A history of diabetes was found in 900 patients (16%), 41% of whom were female. Among the diabetic patients, 755 (84%) died during follow-up, compared with 3,200 (70%) among the non-diabetic patients, resulting in a risk ratio (RR) of death in diabetic patients of 1.5 (95% confidence interval [CI] 1.4 to 1.6, p < 0.0001). In a multivariate analysis, the RR of death in diabetic patients was 1.5 (CI 1.3 to 1.76, p < 0.0001), but a significant interaction between diabetes and gender was found. Diabetes increased the mortality risk more in women than in men, with the RR for diabetic men being 1.4 (95% CI 1.3 to 1.6, p < 0.0001) and 1.7 for diabetic women (95% CI 1.4 to 1.9, p < 0.0001). The effect of diabetes on mortality was similar in patients with depressed and normal left ventricular systolic function.Conclusions Diabetes is a potent, independent risk factor for mortality in patients hospitalized with HF. The excess risk in diabetic patients appears to be particularly prominent in females.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the DIAMOND trial, T2DM was associated with a higher risk of mortality in both ischaemic and non-ischaemic HF.
“In the DIAMOND trial, T2DM was associated with a higher risk of mortality in both ischaemic and non-ischaemic HF. 100”
From Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology (2018) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 36 · Cited by 258
Part of this paper’s reference list could not be split into single entries.
- Authors
- Gustafsson, I., Brendorp, B., Seibæk, M., Burchardt, H., Hildebrandt, P., Køber, L., & Torp-Pedersen, C.
- Affiliations
- Frederiksberg Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Bispebjerg Hospital (DK)
- Corresponding author
- Gustafsson, Ida
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 43
- Issue
- 5
- Pages
- 771-777
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1976410426
- Cited by
- 258
- References
- 36
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 10 · 2023: 11 · 2022: 12 · 2021: 5 · 2020: 19 · 2019: 15 · 2018: 19 · 2017: 18 · 2016: 11 · 2015: 9 · 2014: 14 · 2013: 8 · 2012: 13
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- diabetes mellitus, congestive heart failure, mortality risk, sex differences, prognostic factors, left ventricular systolic function, hospitalization
- MeSH terms
- Aged, Aged, 80 and over, Denmark, Female, Follow-Up Studies, Heart Failure, Hospitalization, Humans, Male, Middle Aged, Prognosis, Risk Factors, Sex Factors, Time Factors, Survival Analysis, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review